Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
FREMONT, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Related news for (CTKB)
- Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
- Don’t Miss Out: MoBot’s Latest Stock Updates 06/04/25 05:00 PM
- MoBot’s Stock Market Highlights – 06/04/25 04:00 PM
- MoBot alert highlights: NASDAQ: CTKB, NASDAQ: LYEL, NYSE: NCL, NYSE: BURU, NASDAQ: MFI (06/04/25 03:00 PM)
- Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
